NICE Recommends New Cervical Cancer Treatment for NHS Patients With Recurrent or Metastatic Disease
NICE has recommended a new NHS treatment option for recurrent or metastatic cervical cancer in England.
NICE and MHRA decisions, newly approved medicines and treatments, and the rules that govern how care is delivered.
NICE Draft PMOS Guideline Could Speed Diagnosis and Annual Care Reviews
NICE has proposed earlier PMOS diagnosis and annual reviews to improve long-term monitoring and care in the NHS.
NICE Recommends New NHS Treatment Option for Recurrent Cervical Cancer
NICE has recommended a new NHS treatment option for recurrent or metastatic cervical cancer in England.
NICE backs first new NHS treatment in more than 20 years for resistant ovarian cancer
NICE recommends the first new NHS treatment in over 20 years for resistant ovarian cancer, offering a targeted option for eligible patients.
NICE Recommends New Pathway for Women With Resistant Ovarian Cancer
NICE recommends a new NHS treatment for resistant ovarian cancer, the first in over 20 years, offering fresh hope for patients.
NICE Opens the Door to a New NHS Option for Recurrent or Metastatic Cervical Cancer
NICE has recommended a new NHS treatment option for recurrent or metastatic cervical cancer, expanding care choices in England.
NICE backs first treatment option for uncontrolled myasthenia gravis in a UK NHS milestone
NICE has backed the first treatment option for uncontrolled generalised myasthenia gravis on the NHS.
NICE backs faster NHS access to hybrid closed-loop diabetes care for people with type 1 diabetes
NICE is advancing draft guidance on hybrid closed-loop diabetes technology as the NHS pushes faster access to innovation.
NICE Recommends First New NHS Treatment in Over 20 Years for Resistant Ovarian Cancer
NICE recommends mirvetuximab soravtansine, the first new NHS ovarian cancer treatment in over 20 years.
NICE Recommends Routine NHS Use of Pregnancy-Specific Artificial Pancreas for Type 1 Diabetes
NICE recommends a pregnancy-specific artificial pancreas for women with type 1 diabetes, paving the way for NHS access.
